Consolidated Balance Sheet
Assets(¥ million)
|
119th period |
120th period |
Month of Settlement |
March 2023 |
March 2024 |
Current Assets |
39,273 |
38,639 |
Fixed Assets |
29,849 |
29,400 |
Breakdown |
Tangible fixed Assets |
23,467 |
22,838 |
Intangible fixed assets |
1,233 |
985 |
Investment and other assets |
5,148 |
5,576 |
Total Assets |
69,123 |
68,039 |
Liabilities(¥ million)
|
119th period |
120th period |
Month of settlement |
March 2023 |
March 2024 |
Current liabilities |
19,178 |
16,880 |
Fixed Liabilities |
9,341 |
9,455 |
Total liabilities |
28,519 |
26,336 |
Net Assets(¥ million)
|
119th period |
120th period |
Settlement Date |
March 2023 |
March 2024 |
Stockholders' Equity |
39,562 |
40,219 |
Breakdown |
Capital |
5,451 |
5,451 |
Capital Surplus |
4,186 |
4,186 |
Retained Earnings |
30,127 |
31,233 |
Treasury Stock |
△203 |
△652 |
Accumulated Other Comprehensive Income |
1,041 |
1,484 |
Breakdown |
Valuation Difference on Other Securities |
223 |
362 |
Foreign Currency Translation Adjustment Account |
10 |
81 |
Accumulated Adjustment for Retirement Benefits |
807 |
1,040 |
Total Net Assets |
40,603 |
41,703 |
Total Liabilities and Net Assets |
69,123 |
68,039 |
Consolidated Statement of Income
(¥ million)
|
119th period |
120th period |
Month of settlement |
March 2023 |
March 2024 |
Net sales |
45,560 |
46,859 |
Cost of sales |
32,586 |
32,988 |
Gross profit |
12,974 |
13,871 |
Selling, general and administrative expenses |
11,365 |
11,798 |
Other income |
284 |
303 |
Other expenses |
145 |
175 |
Ordinary income |
1,748 |
2,201 |
Extraordinary income |
1,683 |
71 |
Extraordinary loss |
- |
- |
Income before income taxes |
3,431 |
2,273 |
Corporate tax, etc |
1,059 |
445 |
Net income |
2,371 |
1,827 |
Net income attributable to non-controlling shareholders |
- |
- |
Net income attributable to owners of parent |
2,371 |
1,827 |
Consolidated Cash Flow
(¥ million)
|
119th period |
120th period |
Month of settlement |
March 2023 |
March 2024 |
Cash flows from operating activities |
2,917 |
3,187 |
Cash flows from investing activities |
△1,153 |
△3,692 |
Cash flows from financing activities |
△867 |
△1,225 |
Exchange differences on cash and cash equivalents |
11 |
27 |
Change in cash and cash equivalents |
908 |
1,702 |
Cash and cash equivalents at beginning of year |
13,844 |
14,752 |
Cash and cash equivalents at end of year |
14,752 |
13,049 |
Capital Investment and Depreciation
Financial and Performance Information